Stocks
Sysmex CorporationSSMXY
OTCHealthcareDiagnostics & Research$8.67-0.46%
A global leader in in-vitro diagnostics, this company specializes in hematology analyzers and reagents for clinical testing. Investors monitor its performance due to its strong position in automated blood analysis systems and expansion into molecular diagnostics.
Market Cap: $5.4B52W Range: $8.15 – $19.85
Congressional Interest in Sysmex Corporation (SSMXY)
5 members of Congress have disclosed 18 trades in Sysmex Corporation (SSMXY), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 11 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
18
Unique Politicians
5
Buys
7
Sells
11
Who in Congress Is Trading SSMXY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-09-22 | Josh Gottheimer | buy | $1K – $15K |
| 2025-08-21 | Josh Gottheimer | sell | $1K – $15K |
| 2025-04-09 | Josh Gottheimer | sell | $1K – $15K |
| 2024-09-09 | Josh Gottheimer | buy | $1K – $15K |
| 2024-09-03 | Josh Gottheimer | buy | $1K – $15K |
| 2024-05-06 | Josh Gottheimer | buy | $1K – $15K |
| 2024-05-02 | Josh Gottheimer | buy | $1K – $15K |
| 2023-07-10 | Daniel Goldman | sell | $15K – $50K |
| 2023-02-27 | Daniel Goldman | sell | $1K – $15K |
| 2021-02-17 | Peter Meijer | sell | $15K – $50K |
| 2021-01-28 | Peter Meijer | sell | $1K – $15K |
| 2020-08-04 | Greg Gianforte | buy | $15K – $50K |
| 2020-01-13 | Greg Gianforte | sell | $15K – $50K |
| 2019-06-24 | Donna Shalala | sell | $1K – $15K |
| 2018-12-21 | Greg Gianforte | buy | $15K – $50K |
| 2018-09-18 | Josh Gottheimer | sell | $1K – $15K |
| 2018-09-12 | Greg Gianforte | sell | $50K – $100K |
| 2018-07-05 | Greg Gianforte | sell | $15K – $50K |